These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13959659)

  • 1. [Farber's disease].
    FREYCON MT
    Pediatrie; 1962; 17():961-2. PubMed ID: 13959659
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated lipogranulomatosis (Farber's disease).
    ZETTERSTROM R
    Acta Paediatr (Stockh); 1958 Sep; 47(5):501-10. PubMed ID: 13582627
    [No Abstract]   [Full Text] [Related]  

  • 3. Farber's disease. Report of a case with observations on its histogenesis and notes on the nature of the stored material.
    ABUL-HAJ SK; MARTZ DG; DOUGLAS WF; GEPPERT LJ
    J Pediatr; 1962 Aug; 61():221-32. PubMed ID: 13859108
    [No Abstract]   [Full Text] [Related]  

  • 4. [DISSEMINATED lipogranulomatosis (Farberl's disease)].
    Actual Pediatr (Granada); 1959 Jul; 16():1-6. PubMed ID: 13856526
    [No Abstract]   [Full Text] [Related]  

  • 5. Subtle clues to diagnosis of skin diseases by electron microscopy. "Farber bodies" in disseminated lipogranulomatosis (Farber's disease).
    Schmoeckel C
    Am J Dermatopathol; 1980; 2(2):153-6. PubMed ID: 7246981
    [No Abstract]   [Full Text] [Related]  

  • 6. Farber's disease (lipogranulomatosis).
    Sisson TR
    Am J Dis Child; 1971 Dec; 122(6):513-4. PubMed ID: 5171854
    [No Abstract]   [Full Text] [Related]  

  • 7. [A rare neurolipidosis with subcutaneous and articular nodular lesions: Farber's lipogranulomatosis].
    Battin J; Vital C; Azanza X
    Bord Med; 1970 Oct; 3(10):2464. PubMed ID: 5536410
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial lipogranulomatosis (Farber's disease).
    Amirhakimi GH; Haghighi P; Ghalambor MA; Honari S
    Clin Genet; 1976 Jun; 9(6):625-30. PubMed ID: 1277575
    [No Abstract]   [Full Text] [Related]  

  • 9. First case of surgical treatment of Farber's disease.
    Haraoka G; Muraoka M; Yoshioka N; Wakami S; Hayashi I
    Ann Plast Surg; 1997 Oct; 39(4):405-10. PubMed ID: 9339283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farber's lipogranulomatosis.
    Vaidya VU; Bharucha BA; Kagalwala TY; Pandya AL; Kumta NB
    Indian Pediatr; 1987 Aug; 24(8):673-5. PubMed ID: 3327826
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case report of childhood Farber's disease and literature review].
    Bao XH; Tian JM; Ji TY; Chang XZ
    Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):54-58. PubMed ID: 28072961
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinopathy in a case of Farber's lipogranulomatosis.
    Cogan DG; Kuwabara T; Moser H; Hazard GW
    Arch Ophthalmol; 1966 Jun; 75(6):752-7. PubMed ID: 5936802
    [No Abstract]   [Full Text] [Related]  

  • 13. [Farber's disease (disseminated lipogranulomatosis). Clinical picture and summary of the chemical findings].
    Rampini S; Clausen J
    Helv Paediatr Acta; 1967 Dec; 22(6):500-15. PubMed ID: 4232884
    [No Abstract]   [Full Text] [Related]  

  • 14. Farber lipogranulomatosis type 1--late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation.
    Cvitanovic-Sojat L; Gjergja Juraski R; Sabourdy F; Fensom AH; Fumic K; Paschke E; Levade T
    Eur J Paediatr Neurol; 2011 Mar; 15(2):171-3. PubMed ID: 20609603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indicative radiologic features in disseminated lipogranulomatosis (Farber's disease)].
    Dihlmann W
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Jul; 117(1):47-51. PubMed ID: 4341608
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of Farber's disease--histochemical, electron microscopic and biochemical studies].
    Hamanaka S; Hara A; Otsuka F
    Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):629-34. PubMed ID: 1920894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Farber's disease (disseminated lipogranulomatosis) (author's transl)].
    Schönenberg H; Lindenfelser R
    Monatsschr Kinderheilkd (1902); 1974 Apr; 122(4):153-9. PubMed ID: 4832028
    [No Abstract]   [Full Text] [Related]  

  • 18. Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course.
    Samuelsson K; Zetterström R
    Scand J Clin Lab Invest; 1971 Jun; 27(4):393-405. PubMed ID: 5109101
    [No Abstract]   [Full Text] [Related]  

  • 19. [A rare neurolipidosis with subcutaneous and articular node lesions: disseminated Farber's lipogranulomatosis].
    Battin J; Vital C; Azanza X
    Ann Dermatol Syphiligr (Paris); 1970; 97(3):241-8. PubMed ID: 5455224
    [No Abstract]   [Full Text] [Related]  

  • 20. Brief Report: Peripheral Osteolysis in Adults Linked to ASAH1 (Acid Ceramidase) Mutations: A New Presentation of Farber's Disease.
    Bonafé L; Kariminejad A; Li J; Royer-Bertrand B; Garcia V; Mahdavi S; Bozorgmehr B; Lachman RL; Mittaz-Crettol L; Campos-Xavier B; Nampoothiri S; Unger S; Rivolta C; Levade T; Superti-Furga A
    Arthritis Rheumatol; 2016 Sep; 68(9):2323-7. PubMed ID: 26945816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.